Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

436 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Active, Not Recruiting

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

NCT04598919

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Baylor University Medical Center (BUMC) Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

NCT02951416

Conditions
Diffuse Parenchymal Lung Diseases, Idiopathic Interstitial Pneumonia, Idiopathic Interstitial Pneumonias, +6 more
Locations
  • Medizinische Universität Wien Vienna, Austria
  • Centre Hospitalier Universitaire Dijon Dijon, France
  • Hopital Bichat Paris Paris, France
  • Andreas Guenther Giessen, Germany
View Trial Details
Active, Not Recruiting

Changes in iOS in IPF

NCT04572958

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Royal Brompton and Harefield hospitals London, Gb-lnd, United Kingdom
View Trial Details

Related conditions